What's breaking now, across thousands of outlets.
CAR-T therapy has revolutionized blood cancer treatment, particularly in multiple myeloma. But an ongoing concern remains: If patients’ cancers progress after receiving CAR-T, what other options do they have? A Phase 2 study at Bristol ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
Lead researcher Darrell Green told Newsweek that the reduced fat gain findings were "completely unexpected."
Glasson Lakehouse in Co Westmeath closed two weeks ago on foot of public health guidance
Sandoz CEO Richard Saynor warns steep U.S. tariffs on imported generic drugs could force manufacturers to raise prices or cut supply.
Roivant drug delivers mid-stage results, Moonwalk raises funds to develop longer-lasting obesity drugs, and more biotech news
A new drug shows promise in reducing the symptoms of COPD, one of the top 10 leading cause of death in the U.S., according to the CDC.
LONDON — Sandoz is betting big on its newly formed biosimilar unit, as it reveals plans to grow its pipeline there by more than sevenfold and also invests $300 million in a new biosimilar…
